tirzepatide cardiovascular trial and Outcomes: A Narrative Review of Mechanisms, Efficacy and Implications for Heart Failure Management Tirzepatide in SURPASS‑CVOT: Favorable Cardiovascular

McGill and Jaeschke 2014) and to biomarkers that are amenable to measurement within biofluids that are easy to obtain in humans (e.g., blood and urine)

This gradual approach can help reduce any Tirzepatide withdrawal symptoms and give your body time to adapt naturally

doi: 10.1002/art.24225 132 XueJ-FShiZ-MZouJLiX-L

Pain in the rib joints, such as in a condition called costochondritis, can also cause chest discomfort

Peer review Peer review information Communications Biology thanks Marcelo Comini and the other, anonymous, reviewer(s) for their contribution to the peer review of this work

Clinical Status Human RCT | Observational | Animal | In vitro Evaluated in multiple human clinical trials for obesity and metabolic regulation research